Detection and management of early melanoma in 2023 | RACGP ACCREDITED | 93 mins
GPs are at the frontline of melanoma diagnosis and are becoming increasingly confronted with the management of melanoma. Early detection, diagnosis and treatment of...
Neoadjuvant immunotherapy: Revolutionising melanoma treatment | 36 min
Our latest podcast explores the innovative approach of neoadjuvant immunotherapy – administering checkpoint inhibitor immunotherapy before the surgical removal of melanoma. This promising approach...
The role of PRAME immunohistochemistry in the diagnostic approach to melanocytic lesions | 30 min
PRAME is a tumour-associated antigen identified by autologous T-cell epitope in a patient with metastatic cutaneous melanoma. In this presentation Pathologist Dr Robert Rawson...
Managing immunotherapy side effects | 54 min
Nurses are instrumental in ensuring immunotherapy is delivered safely to their patients. Managing toxicities, educating patients and ensuring patients receive the right care at...
Unravelling lentigo maligna | 48 min
Lentigo maligna – a subtype of in situ melanoma – presents diagnostic and treatment challenges for clinicians. In this podcast, Dr Michael Rtshiladze leads...
Getting the most out of pathology to help manage pigmented lesions | 62 min
Differentiating melanoma from benign nevi can be a challenge for both GPs and pathologists, but an accurate diagnosis — particularly if it is melanoma...
The critical role of standardised pathological assessment in neoadjuvant therapy for melanoma: A guide for Pathologists | 40 min
The role of the Pathologist is crucial in the emerging field of neoadjuvant therapy in melanoma. Understanding that their role is fundamental to patient...
Diagnosis and management of uveal melanoma | 44 min
Despite recent advances in management of primary uveal melanoma, more than half of patients develop metastatic disease – often with poor outcomes. New therapeutic...
Surgical management of early stage melanoma | 31 min
In this presentation, Surgical Oncologist Prof Andrew Spillane discusses: • management of the primary tumour • the role of sentinel lymph node biopsy and...